Authors’ Reply to Katsuhiro Toda’s Comment on “Proton Pump Inhibitor Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case-Control Analysis”

Drug Safety - United Kingdom
doi 10.1007/s40264-018-0741-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comment on “Proton Pump Inhibitor Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case–Control Analysis”

Drug Safety
ToxicologyPharmacology
2018English

Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study

Journal of the American Geriatrics Society
GerontologyGeriatrics
2017English

Letter: Proton Pump Inhibitor Use and Risk of Fracture

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Moving Towards Appropriate Use of Proton Pump Inhibitors. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Association Between Proton Pump Inhibitor Use and Fracture Risk - Causality or Confounding?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease

Gastroenterology
HepatologyGastroenterology
2017English

Editorial: Is Proton Pump Inhibitor Use Associated With Worse Outcomes in Patients With Liver Abscesses? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

A Nationwide Nested Case-Control Study Indicates an Increased Risk of Acute Interstitial Nephritis With Proton Pump Inhibitor Use

Kidney International
Nephrology
2014English

Use of Proton Pump Inhibitors and Subsequent Risk of Celiac Disease

Digestive and Liver Disease
HepatologyGastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy